Regeneron Pharmaceuticals (REGN) Capital Expenditures Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.57% |
| Dec 31, 2025 | 24.60% |
| Sep 30, 2025 | 16.36% |
| Jun 30, 2025 | -385.31% |
| Mar 31, 2025 | 71.25% |
| Dec 31, 2024 | -20.60% |
| Sep 30, 2024 | 3.29% |
| Jun 30, 2024 | 117.22% |
| Mar 31, 2024 | -24.86% |
| Dec 31, 2023 | 65.18% |
| Sep 30, 2023 | 174.95% |
| Jun 30, 2023 | -166.93% |
| Mar 31, 2023 | 25.67% |
| Dec 31, 2022 | -1.74% |
| Sep 30, 2022 | 6.98% |
| Jun 30, 2022 | -18.73% |
| Mar 31, 2022 | 89.57% |
| Dec 31, 2021 | -4.03% |
| Sep 30, 2021 | -13.05% |
| Jun 30, 2021 | 45.50% |
| Mar 31, 2021 | -56.03% |
| Dec 31, 2020 | 16.12% |
| Sep 30, 2020 | 25.88% |
| Jun 30, 2020 | 37.32% |
| Mar 31, 2020 | 128.94% |
| Dec 31, 2019 | 62.57% |
| Sep 30, 2019 | 14.60% |
| Jun 30, 2019 | -15.54% |
| Mar 31, 2019 | -6.42% |
| Dec 31, 2018 | -20.57% |
| Sep 30, 2018 | 78.03% |
| Jun 30, 2018 | 104.20% |
| Mar 31, 2018 | 57.35% |
| Dec 31, 2017 | -28.44% |
| Sep 30, 2017 | -49.68% |
| Jun 30, 2017 | -60.49% |
| Mar 31, 2017 | -51.52% |
| Dec 31, 2016 | -15.39% |
| Sep 30, 2016 | -18.85% |
| Jun 30, 2016 | -42.13% |
| Mar 31, 2016 | -8.82% |
| Dec 31, 2015 | 51.25% |
| Sep 30, 2015 | 83.15% |
| Jun 30, 2015 | 238.48% |
| Mar 31, 2015 | 76.12% |
| Dec 31, 2014 | 70.41% |
| Sep 30, 2014 | 151.71% |
| Jun 30, 2014 | 105.71% |
| Mar 31, 2014 | 205.72% |
| Dec 31, 2013 | 354.93% |
| Sep 30, 2013 | 209.24% |
| Jun 30, 2013 | 167.66% |
| Mar 31, 2013 | 91.80% |
| Dec 31, 2012 | 34.31% |
| Sep 30, 2012 | 15.17% |
| Jun 30, 2012 | -13.40% |
| Mar 31, 2012 | -50.13% |
| Dec 31, 2011 | -65.01% |
| Sep 30, 2011 | -59.74% |
| Jun 30, 2011 | -34.17% |
| Mar 31, 2011 | -2.54% |
| Dec 31, 2010 | 44.57% |
| Sep 30, 2010 | -1.02% |